130 related articles for article (PubMed ID: 28188270)
1. Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP
Koepple C; Scherer D; Seyler C; Scholz E; Thomas D; Katus HA; Zitron E
J Pharmacol Exp Ther; 2017 May; 361(2):209-218. PubMed ID: 28188270
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP
Scherer D; Schworm B; Seyler C; Xynogalos P; Scholz EP; Thomas D; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jul; 390(7):701-710. PubMed ID: 28365825
[TBL] [Abstract][Full Text] [Related]
3. Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.
Xynogalos P; Seyler C; Scherer D; Koepple C; Scholz EP; Thomas D; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1153-61. PubMed ID: 25182566
[TBL] [Abstract][Full Text] [Related]
4. Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP
Xynogalos P; Rahm AK; Fried S; Chasan S; Scherer D; Seyler C; Katus HA; Frey N; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):659-667. PubMed ID: 36445385
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.
López-Izquierdo A; Aréchiga-Figueroa IA; Moreno-Galindo EG; Ponce-Balbuena D; Rodríguez-Martínez M; Ferrer-Villada T; Rodríguez-Menchaca AA; van der Heyden MA; Sánchez-Chapula JA
Pflugers Arch; 2011 Oct; 462(4):505-17. PubMed ID: 21779761
[TBL] [Abstract][Full Text] [Related]
6. Long polyamines act as cofactors in PIP2 activation of inward rectifier potassium (Kir2.1) channels.
Xie LH; John SA; Ribalet B; Weiss JN
J Gen Physiol; 2005 Dec; 126(6):541-9. PubMed ID: 16316973
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP
Ha J; Xu Y; Kawano T; Hendon T; Baki L; Garai S; Papapetropoulos A; Thakur GA; Plant LD; Logothetis DE
J Biol Chem; 2018 Mar; 293(10):3546-3561. PubMed ID: 29317494
[TBL] [Abstract][Full Text] [Related]
8. Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
Amorós I; Dolz-Gaitón P; Gómez R; Matamoros M; Barana A; de la Fuente MG; Núñez M; Pérez-Hernández M; Moraleda I; Gálvez E; Iriepa I; Tamargo J; Caballero R; Delpón E
Biochem Pharmacol; 2013 Jul; 86(2):267-78. PubMed ID: 23648307
[TBL] [Abstract][Full Text] [Related]
9. Inward rectification by polyamines in mouse Kir2.1 channels: synergy between blocking components.
Xie LH; John SA; Weiss JN
J Physiol; 2003 Jul; 550(Pt 1):67-82. PubMed ID: 12740427
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.
Kiesecker C; Zitron E; Scherer D; Lueck S; Bloehs R; Scholz EP; Pirot M; Kathöfer S; Thomas D; Kreye VA; Kiehn J; Borst MM; Katus HA; Schoels W; Karle CA
J Mol Med (Berl); 2006 Jan; 84(1):46-56. PubMed ID: 16258766
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
[TBL] [Abstract][Full Text] [Related]
12. Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine.
Noujaim SF; Stuckey JA; Ponce-Balbuena D; Ferrer-Villada T; López-Izquierdo A; Pandit SV; Sánchez-Chapula JA; Jalife J
Cardiovasc Res; 2011 Mar; 89(4):862-9. PubMed ID: 21233253
[TBL] [Abstract][Full Text] [Related]
13. The antimalarial drug mefloquine inhibits cardiac inward rectifier K+ channels: evidence for interference in PIP2-channel interaction.
López-Izquierdo A; Ponce-Balbuena D; Moreno-Galindo EG; Aréchiga-Figueroa IA; Rodríguez-Martínez M; Ferrer T; Rodríguez-Menchaca AA; Sánchez-Chapula JA
J Cardiovasc Pharmacol; 2011 Apr; 57(4):407-15. PubMed ID: 21502926
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol inhibits Kir2.3 channels by interference with PIP₂-channel interaction.
Ferrer T; Ponce-Balbuena D; López-Izquierdo A; Aréchiga-Figueroa IA; de Boer TP; van der Heyden MA; Sánchez-Chapula JA
Eur J Pharmacol; 2011 Oct; 668(1-2):72-7. PubMed ID: 21663737
[TBL] [Abstract][Full Text] [Related]
15. Kir2.x inward rectifier potassium channels are differentially regulated by adrenergic alpha1A receptors.
Zitron E; Günth M; Scherer D; Kiesecker C; Kulzer M; Bloehs R; Scholz EP; Thomas D; Weidenhammer C; Kathöfer S; Bauer A; Katus HA; Karle CA
J Mol Cell Cardiol; 2008 Jan; 44(1):84-94. PubMed ID: 18035370
[TBL] [Abstract][Full Text] [Related]
16. Electrostatics in the cytoplasmic pore produce intrinsic inward rectification in kir2.1 channels.
Yeh SH; Chang HK; Shieh RC
J Gen Physiol; 2005 Dec; 126(6):551-62. PubMed ID: 16316974
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gating by negative charges in the cytoplasmic pore in the Kir2.1 channel.
Xie LH; John SA; Ribalet B; Weiss JN
J Physiol; 2004 Nov; 561(Pt 1):159-68. PubMed ID: 15459242
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol-4,5-bisphosphate (PIP2) regulation of strong inward rectifier Kir2.1 channels: multilevel positive cooperativity.
Xie LH; John SA; Ribalet B; Weiss JN
J Physiol; 2008 Apr; 586(7):1833-48. PubMed ID: 18276733
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of Kir currents by antihistamines.
Liu B; Jia Z; Geng X; Bei J; Zhao Z; Jia Q; Zhang H
Eur J Pharmacol; 2007 Mar; 558(1-3):21-6. PubMed ID: 17214982
[TBL] [Abstract][Full Text] [Related]
20. The effects of oxidizing and cysteine-reactive reagents on the inward rectifier potassium channels Kir2.3 and Kir1.1.
Bannister JP; Young BA; Main MJ; Sivaprasadarao A; Wray D
Pflugers Arch; 1999 Nov; 438(6):868-78. PubMed ID: 10591077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
